invasive ductal carcinoma

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf gptkb:disease
gptkb:breast_cancer_subtype
gptkbp:affects breast tissue
gptkbp:alsoKnownAs gptkb:IDC
gptkbp:canBe HER2 positive
hormone receptor positive
triple negative
gptkbp:canMetastasizeTo brain
lungs
liver
lymph nodes
bones
gptkbp:canProgressTo gptkb:ductal_carcinoma_in_situ
gptkbp:commonIn gptkb:women
gptkbp:diagnosedBy ultrasound
biopsy
mammography
gptkbp:firstDescribed gptkb:19th_century
gptkbp:ICD-10_code C50
gptkbp:mostCommonTypeOf gptkb:cancer
gptkbp:occurredIn men
gptkbp:originatedIn ductal epithelium
gptkbp:percentageOfBreastCancers 70-80%
gptkbp:prognosis lymph node involvement
tumor size
hormone receptor status
histological grade
HER2 status
gptkbp:relatedTo gptkb:ductal_carcinoma_in_situ
gptkbp:riskFactor gptkb:BRCA1_mutation
age
family history
alcohol consumption
obesity
hormone replacement therapy
early menarche
late menopause
BRCA2 mutation
gptkbp:symptom nipple discharge
breast pain
skin changes
breast lump
gptkbp:treatment gptkb:radiation_therapy
gptkb:targeted_therapy
surgery
chemotherapy
hormone therapy
gptkbp:bfsParent gptkb:ductal_carcinoma_in_situ
gptkb:triple-negative_breast_cancer
gptkb:BT20
gptkbp:bfsLayer 8
https://www.w3.org/2000/01/rdf-schema#label invasive ductal carcinoma